Provided by Tiger Fintech (Singapore) Pte. Ltd.

Ashland

57.78
-1.5100-2.55%
Post-market: 57.780.00000.00%16:20 EDT
Volume:771.30K
Turnover:44.50M
Market Cap:2.73B
PE:-126.01
High:59.15
Open:59.15
Low:57.11
Close:59.29
Loading ...

Press Release: SELLAS Life Sciences Reports Full Year 2024 Financial Results and Provides Corporate Update

Dow Jones
·
21 Mar

Press Release: Autolus Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Business Updates

Dow Jones
·
20 Mar

Ashland Wraps Up Divestment of Avoca Business to Mane

Zacks
·
18 Mar

Metagenomi Reports Business Updates and Full Year 2024 Financial Results

GlobeNewswire
·
18 Mar

Mizuho Cuts Price Target on Ashland to $68 From $85, Keeps Outperform Rating

MT Newswires Live
·
17 Mar

Ashland Inc: Financial Terms of Transaction Were Not Disclosed.

THOMSON REUTERS
·
17 Mar

Ashland Completes Sale of Avoca Business to Mane

THOMSON REUTERS
·
17 Mar

Ashland completes sale of Avoca business to Mane

GlobeNewswire
·
17 Mar

Are Options Traders Betting on a Big Move in Ashland (ASH) Stock?

Zacks
·
14 Mar

Press Release: Rallybio Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Updates

Dow Jones
·
13 Mar

Press Release: Prelude Therapeutics Reports Full Year 2024 Financial Results and Provides Program Outlook for 2025

Dow Jones
·
10 Mar

Seaport Global downgrades Ashland (ASH) to a Hold

TIPRANKS
·
08 Mar

Press Release: Molecular Partners Reports Highlights from Q4 2024 and Key Financials for Full Year 2024

Dow Jones
·
07 Mar

Fate Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Business Updates

GlobeNewswire
·
06 Mar

Ashland Cut to Neutral From Buy by Seaport Global

Dow Jones
·
05 Mar

Seaport Research downgrades chemicals trio to Neutral

TIPRANKS
·
05 Mar